Myriad Genetics First Quarter 2026 Financial Earnings

5/5/2026 | 1:30 pm PST / 4:30pm EST

Webcast Link
View Presentation

Events & Presentations

  • Myriad Genetics First Quarter 2026 Financial Earnings

    05/05/2026 | 1:30pm PDT / 4:30pm EDT

  • Barclays 28th Annual Global Healthcare Conference

    03/11/2026 | 9:00pm PDT / 12:00am EDT

  • Leerink Partners Global Healthcare Conference

    03/10/2026 | 10:40am PDT / 1:40pm EDT

Financial Reports and Filings

Date Filing Title Downloads
05/06/2026 10-Q Quarterly report which provides a continuing view of a company's financial position RTF XLS PDF HTML XBRL
05/05/2026 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
05/04/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
04/15/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
04/15/2026 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
04/14/2026 ARS An annual report to security holders RTF XLS PDF HTML XBRL
04/14/2026 DEFA14A Additional proxy soliciting materials - definitive RTF XLS PDF HTML XBRL
04/14/2026 DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") RTF XLS PDF HTML XBRL
04/07/2026 SCHEDULE 13G/A SCHEDULE 13G/A - Description RTF XLS PDF HTML XBRL
03/27/2026 SCHEDULE 13G/A SCHEDULE 13G/A - Description RTF XLS PDF HTML XBRL

Latest News

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences Thumbnail

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

May 07, 2026 | Financial

Read more
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business Thumbnail

Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business

May 05, 2026 | Financial

Read more
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan Thumbnail

Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan

Apr 30, 2026 | Products

Read more

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.

Quality, Innovation and Corporate Responsibility Report

Myriad Genetics has a strong commitment to operational excellence, innovation and being a good corporate partner. Our dedication to these important issues serve as the foundation to achieving our mission of advancing health and well-being for all.

Learn more about the actions we’re taking in quality, innovation, and corporate responsibility.